Elderly patients with kidney failure get kidney transplants more often than they did a decade ago, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The results suggest that the chances of receiving a kidney transplant are better than ever for an older patient who needs one.
Kidney failure afflicts nearly half a million individuals in the United States, and 48% of sufferers are 60 years of age or older. Kidney disease patients who obtain a transplant live longer than those that remain on dialysis. Fortunately, living and deceased organ donations are on the rise; however, transplant waiting lists have become increasingly long as more and more people develop kidney dysfunction.
Elke Schaeffner, MD (Charité University Medicine, in Berlin, Germany), along with Caren Rose and John Gill, MD (St. Paul's Hospital, University of British Columbia, in Vancouver, Canada) examined whether elderly patients with kidney failure have better or worse access to transplants now than they did in the past. The study included patients with kidney failure in the United States aged 60 to 75 years listed in the United States Renal Data System between 1995 and 2006.
The study revealed that elderly patients rarely receive a transplant, but they were twice as likely to get one in 2006 as in 1995. (In 2006, they had a 7.3% likelihood of getting a transplant within three years of their first treatment for kidney failure.) Elderly patients now benefit from greater access to organs from living donors and older deceased donors compared to a decade ago. They also die less frequently while waiting for a kidney than they did in the past.
The authors urge clinicians to encourage elderly patients with kidney disease to consider transplantation over other forms of treatment. "Early engagement and education of patients and their families about the benefits and opportunities for transplantation may lead to further increases in the use of... transplantation in this age group. Policy changes and research are also needed to further expand access to transplantation in the elderly," they wrote.
In reviewing the results of this study in an accompanying editorial, Suphamai Bunnapradist, MD and Gabriel Danovitch, MD (David Geffen School of Medicine at the University of California, Los Angeles) noted that elderly patients' probability of receiving a transplant in the latter part of the study period remained quite small and that barriers to transplantation are more pronounced in elderly candidates. "Practitioners should consider in a careful and compassionate manner whether transplantation is a realistic option for each elderly end-stage renal disease candidate," they wrote. "Each transplant program must carefully consider the most cost-effective and clinically rational manner in which their elderly candidates are evaluated and managed while on the waiting list."
Disclosures: The authors of the study and the editorial reported no financial disclosures.
The article, entitled "Access to Kidney Transplantation among the Elderly in the United States: A Glass Half Full, not Half Empty," (doi 10.2215/CJN.03490410) and the accompanying editorial "Kidney Transplants for the Elderly: Hope or Hype?" (doi 10.2215/CJN.08731010) will appear online at http://cjasn.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Founded in 1966, the American Society of Nephrology (ASN) is the world's largest professional society devoted to the study of kidney disease. Comprised of 11,000 physicians and scientists, ASN continues to promote expert patient care, to advance medical research, and to educate the renal community. ASN also informs policymakers about issues of importance to kidney doctors and their patients. ASN funds research, and through its world-renowned meetings and first-class publications, disseminates information and educational tools that empower physicians.